Evaluation of hpv risk groups among women enrolled in the mulher cervical cancer screening study in Mozambique
HR-HPV prevalence was high among Mozambican women aged 30-49 years, especially among WLWH, consistent with the high burden of cervical cancer in this population. HPV16 was the most common HR-HPV group among women with cervical cancer. Further study is needed to determine the role of HR-HPV genotyping in follow-up and treatment in Mozambique.
Authors
- Viviane Andrade (ORCID: https://orcid.org/0000-0002-2998-1469)
- Mila Pontremoli Salcedo (ORCID: https://orcid.org/0000-0002-6375-0736)
- Hira Atif
- Nafissa Osman
- Jennifer Carns (ORCID: https://orcid.org/0000-0002-4026-0558)
- Cristina Mendes de Oliveira (ORCID: https://orcid.org/0000-0003-4038-3985)
- Ricardina Rangeiro (ORCID: https://orcid.org/0000-0003-3782-8234)
- Elizabeth Y. Chiao (ORCID: https://orcid.org/0000-0001-5752-2916)
- Rebecca Richards‐Kortum (ORCID: https://orcid.org/0000-0003-2347-9467)
- Ellen Baker
- Andrea Neves
- Kathleen M. Schmeler (ORCID: https://orcid.org/0000-0002-9670-4189)
- Carla Carrilho (ORCID: https://orcid.org/0000-0003-0208-7309)
- Marcos Chissano
- Guilhermina Tivir
- Hannah Hoover
- Edson Chivambo
- Philip E. Castle (ORCID: https://orcid.org/0000-0003-1082-6554)
- Alda Mariano
- Eva Lathrop
- Cesaltina Lorenzoni
- Eliane Maria de Oliveira Monteiro
- Joseph Thomas (ORCID: https://orcid.org/0000-0003-0950-5235)
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Eduardo Mondlane University (MZ)
- Maputo Central Hospital (MZ)
- Population Services International (US)
- National Cancer Institute (US)
- Ministry of Health (MZ)
- Rice University (US)
Publication Details
- Journal
- Infectious Agents and Cancer
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1186/s13027-025-00655-1
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- United States Agency for International Development
- National Academies of Sciences, Engineering, and Medicine
- University of Texas MD Anderson Cancer Center
- National Cancer Institute